These are the stocks posting the largest moves before the bell.Market Insiderread more
More and more American firms are calling for the Trump administration to resolve its conflict with China.World Economyread more
The Fed is not likely to make a move on interest rates when it meets this week, but it should clear the way for a rate cut later in the summer.Market Insiderread more
American Airlines will become first U.S. airline to order new Airbus A321XLR, according to a source familiar with details of the agreement.Paris Air Showread more
Facebook's new cryptocurrency project, titled Libra and backed by the likes of Visa and Booking Holdings, is being widely embraced by market watchers.Trading Nationread more
Huawei CEO Ren Zhengfei tells CNBC the company's business is still strong in China.Technologyread more
U.S. President Donald Trump officially kicked off his reelection campaign Tuesday at a Florida rally where he exhorted thousands of rollicking supporters to keep advancing his...Politicsread more
But BlackRock's global fixed income chief also says he doesn't think the Fed will announce a rate cut until July.Market Insiderread more
As Beijing has raised duties in response to the Trump administration's spate of tariff announcements, it also lowered trade barriers for exporters around the world.Marketsread more
Global watchdogs and top U.S. Congress members are calling for oversight of a digital asset being launched by Facebook and roughly two dozen other stakeholders.Marketsread more
Mortgage applications were down 3.4% from the previous week, but still up 31.6% from a year earlier, according to the Mortgage Bankers Association.Real Estateread more
The Food and Drug Administration on Thursday issued a safety warning following the death of a patient who contracted a drug resistant bacteria that was transmitted during an experimental fecal transplant.
Another patient also fell ill after receiving a transplant, the FDA said. Both adults, who the agency did not identify, had compromised immune systems.
The stool used for both patients' transplants was obtained from the same donor, according to the FDA, and was not tested for E.coli bacteria that produced the beta-lactamase enzyme. An FDA spokeswoman could not immediately provide more details on the death.
"While we support this area of scientific discovery, it's important to note that FMT does not come without risk," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a statement. The FDA said the patient who died received an experimental fecal microbiome transplant, or FMT. "We therefore want to alert all health care professionals who administer FMT about this potential serious risk so they can inform their patients," he said.
The FDA said certain donor screening and stool testing protections are needed for any experimental use of fecal microbiome transplants as a result of the patients falling ill.
Fecal microbiome transplants, also known as stool transplants, are when fecal bacteria from healthy donors are transplanted into a recipient. The FDA has permitted the experimental transplants to be used for certain conditions since 2013.